Healthcare Technology Featured Article

May 09, 2011

Healthcare Technology and News: Catalyst Debuts Catalyst Rx Mobile

Catalyst Rx, subsidiary of Catalyst Health Solutions, Inc. has rolled out its new Catalyst Rx Mobile, a mobile platform built on the latest technology to securely streamline plan, member and claims information to improve medication adherence and reduce healthcare costs for members.

This new platform aids users with information which is best for their health and acts as a trusted advisor, offering important and valuable information at members’ fingertips to empower them to make better health and cost-related decisions and simplify their lives.

Catalyst Rx Mobile reflects our commitment to deliver innovative solutions that improve care while lowering costs for our members,” stated David T. Blair, chief executive officer of Catalyst. “Through our state-of-the-art mobile and web technology and other Generic Advantage Plan initiatives, our goal is to drive generic utilization to more than 80 percent while improving drug adherence.”

The company has built this innovative platform after years of consultation with experts in the areas of pharmacy, behavioral psychology and technology, including mobile health technology company, LiveRx, Inc.

This mobile platform offers variety of tool including the award-winning drug pricing technology that helps members to saves money and plan sponsors by identifying lowest-cost pharmacy options and generic alternatives. It also uses Proprietary drug equivalency technology to allow the members to compare prices across lower cost therapeutic alternatives when a generic equivalent is not available.

Apart from that, users can also use drug look up tool that provides information on common uses of medications, how to take them, possible side effects, and also improves member awareness and safety.

In other news, Catalyst Health Solutions, Inc. and Walgreen Co. recently announced that the Federal Trade Commission (FTC) has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with Catalyst’s previously announced proposed acquisition of Walgreens Health Initiatives, Inc., the pharmacy benefit management subsidiary of Walgreen Co.

Jyothi Shanbhag is a contributing editor for HealthTechZone. To read more of Jyothi's articles, please visit her columnist page.

Edited by Jennifer Russell

FREE eNewsletter

Click here to receive your targeted Healthcare Technology Community eNewsletter.
[Subscribe Now]